Hims & Hers Health, Novo Nordisk end weight loss medication suit, enter collaboration

This is a live story built from multiple sources. It may evolve quickly. A published brief exists for this story.

Coverage meter • 1 hr window

What’s included

Top recent items from this story.

2 items • 2 unique links

Financial Times - Companies 3 weeks ago • ft.com

Hims shares shoot up after weight-loss drug deal with Novo Nordisk

Then undefined per month. Complete digital access to quality FT journalism on any device. Cancel anytime during your trial. Our digitised version of the FT newspaper, for easy reading on any device. Essential digital acc…

Open

ABC News - Business 3 weeks ago • abcnews.com

Hims & Hers Health, Novo Nordisk end weight loss medication suit, enter collaboration

Hims & Hers Health has agreed to stop selling compound versions of Novo Nordisk’s Wegovy and other weight-loss drugs, ending for now a patent lawsuit

Open